eResearchTechnology, Inc. provides services and customizable medical devices to biopharmaceutical organizations and healthcare organizations. It markets centralized cardiac safety and respiratory efficacy services in drug development and also collect, analyze and distribute electronic patient reported outcomes (ePRO) in multiple modalities across all phases of clinical research. The Cardiac Safety solutions include the collection, interpretation and distribution of electrocardiographic data and images and are utilized during clinical trials in all phases of the clinical research process. The Respiratory solutions are utilized in developing new compounds for the treatment of asthma, emphysema, cystic fibrosis and chronic obstructive pulmonary disease to assess the efficacy of a drug or to evaluate compounds that have an effect on pulmonary function. The ePRO solution electronically captures patient self-reported data pertaining to their quality of life and is utilized by sponsors of clinical trials. Its technology-based services improve the accuracy, timeliness and efficiency of trial set-up, data collection from sites worldwide, data interpretation and new drug, biologic and device application submissions. eResearchTechnology was founded in 1977 and is headquartered in Philadelphia, PA.